Physician profile
Eric J Robinson
NPI 1962695668
$2,674.00
in general payments reported to CMS, 2019-2025
21 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $214 · 2021: $56.94 · 2022: $138 · 2023: $524 · 2024: $210 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $704.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $544.81 | 2019-2025 | |
| Medtronic, INC. | $430.44 | 2021-2025 | Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Amgen INC. | $257.60 | 2019-2020 | |
| Shockwave Medical, INC | $105.98 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $78.97 | 2019-2023 | Zio Xt Patch |
| Baxter Healthcare | $71.55 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $71.28 | 2019-2023 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $65.73 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $53.36 | 2019-2025 | |
| Boston Scientific Corporation | $49.10 | 2019 | |
| Philips North America LLC | $40.74 | 2024-2025 | Extended Holter, (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $29.37 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.90 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $27.51 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $26.12 | 2019 | |
| Astellas Pharma US INC | $20.96 | 2019 | |
| Abbott Laboratories | $18.83 | 2022 | |
| Cardiovascular Systems INC. | $17.37 | 2019 | |
| Silk Road Medical, INC. | $15.50 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Atricure, INC. | $14.94 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.